AZN:LSE AstraZeneca PLC

GBX 12,260.00 0.00 0
Icon

AstraZeneca PLC (AZN:LSE) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - General | LSE
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

GBX 12,260.00

0.00 (0.00)%

GBX 187.68B

1.01M

N/A

GBX 10200.00 (-16.80%)

Icon

AZN:LSE

AstraZeneca PLC (GBX)
COMMON STOCK | LSE
GBX 12,260.00
0.00 0
Take a Tour
stockTargetAdvisor

Hold

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bullish

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

GBX 187.68B

GBX 10200.00 (-16.80%)

GBX 12,260.00

AstraZeneca PLC (AZN:LSE) Stock Forecast

GBX 9,900.00
(-19.25%)

Based on the AstraZeneca PLC stock forecast from 2 analysts, the average analyst target price for AstraZeneca PLC is GBX 9,900.00 over the next 12 months. AstraZeneca PLC’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of AstraZeneca PLC is Slightly Bullish , which is based on 11 positive signals and 7 negative signals. At the last closing, AstraZeneca PLC’s stock price was GBX 12,260.00. AstraZeneca PLC’s stock price has changed by +1.69% over the past week, -1.07% over the past month and +18.68% over the last year.

No recent analyst target price found for AstraZeneca PLC
No recent average analyst rating found for AstraZeneca PLC

Company Overview AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga...Read More

https://www.astrazeneca.com

1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA

89,900

December

GBX

UK

Adjusted Closing Price for AstraZeneca PLC (AZN:LSE)

Loading...

Unadjusted Closing Price for AstraZeneca PLC (AZN:LSE)

Loading...

Share Trading Volume for AstraZeneca PLC Shares

Loading...

Compare Performance of AstraZeneca PLC Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for AZN:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To AstraZeneca PLC (Sector: Drug Manufacturers - General )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
GSK:LSE
GlaxoSmithKline PLC 0.00 (0.00%) GBX61.62B 13.86 8.83

ETFs Containing AZN

Symbol Name AZN's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About AstraZeneca PLC (AZN:LSE) Stock

Based on ratings from 2 analysts AstraZeneca PLC's stock is Hold . Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 1 buy, 1 sell and hold ratings.

AZN:LSE stock's dividend yield is 1.90%. Our analysis grades AZN:LSE stock's dividend yield at F. This means that AZN:LSE stock's dividend yield is above 50% of the stocks in the Drug Manufacturers - General sector in the LSE exchange. Based on this AZN:LSE may be a average dividend stock for its sector.

Based on targets from 2 analysts, the average taret price for AZN:LSE is GBX 9,900.00 over the next 12 months. The maximum analyst target price is GBX 9900 while the minimum anlayst target price is GBX 9900.

AZN:LSE stock's Price/Earning ratio is 37.83. Our analysis grades AZN:LSE stock's Price / Earning ratio at F. This means that AZN:LSE stock's Price/Earning ratio is above 50% of the stocks in the Drug Manufacturers - General sector in the LSE exchange. Based on this AZN:LSE may be fairly valued for its sector

The last closing price of AZN:LSE's stock was GBX 12,260.00.

The most recent market capitalization for AZN:LSE is GBX 187.68B.

Based on targets from 2 analysts, the average taret price for AZN:LSE is projected at GBX 9,900.00 over the next 12 months. This means that AZN:LSE's stock price may go down by -19.25% over the next 12 months.

We can't find any ETFs which contains AstraZeneca PLC's stock.

As per our most recent records AstraZeneca PLC has 89,900 Employees.

AstraZeneca PLC's registered address is 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA. You can get more information about it from AstraZeneca PLC's website at https://www.astrazeneca.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...